DK0526529T3 - "Forbedret fremgangsmåde til fremstilling af substituerede indolonderivater" - Google Patents

"Forbedret fremgangsmåde til fremstilling af substituerede indolonderivater"

Info

Publication number
DK0526529T3
DK0526529T3 DK91908508.4T DK91908508T DK0526529T3 DK 0526529 T3 DK0526529 T3 DK 0526529T3 DK 91908508 T DK91908508 T DK 91908508T DK 0526529 T3 DK0526529 T3 DK 0526529T3
Authority
DK
Denmark
Prior art keywords
preparation
improved process
indolone derivatives
substituted indolone
substituted
Prior art date
Application number
DK91908508.4T
Other languages
Danish (da)
English (en)
Inventor
Robert Giles
Timothy Charles Walsgrove
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Application granted granted Critical
Publication of DK0526529T3 publication Critical patent/DK0526529T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/39Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups
    • C07C205/40Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups and esterified hydroxy groups bound to acyclic carbon atoms of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/12Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/78Benzoic acid esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
DK91908508.4T 1990-04-17 1991-04-15 "Forbedret fremgangsmåde til fremstilling af substituerede indolonderivater" DK0526529T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909008605A GB9008605D0 (en) 1990-04-17 1990-04-17 Process

Publications (1)

Publication Number Publication Date
DK0526529T3 true DK0526529T3 (da) 1996-11-18

Family

ID=10674534

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91908508.4T DK0526529T3 (da) 1990-04-17 1991-04-15 "Forbedret fremgangsmåde til fremstilling af substituerede indolonderivater"

Country Status (29)

Country Link
US (1) US5336781A (ja)
EP (1) EP0526529B1 (ja)
JP (2) JP2788548B2 (ja)
KR (1) KR0180215B1 (ja)
CN (1) CN1027892C (ja)
AP (1) AP184A (ja)
AT (1) ATE144251T1 (ja)
AU (2) AU640006B2 (ja)
CA (1) CA2080221C (ja)
CY (1) CY1981A (ja)
DE (1) DE69122753T2 (ja)
DK (1) DK0526529T3 (ja)
ES (1) ES2094812T3 (ja)
FI (1) FI101148B (ja)
GB (1) GB9008605D0 (ja)
GR (1) GR3022261T3 (ja)
HK (1) HK3097A (ja)
HU (1) HU214822B (ja)
IE (1) IE911262A1 (ja)
IL (7) IL97867A (ja)
MA (1) MA22133A1 (ja)
MY (1) MY109628A (ja)
NO (2) NO178396C (ja)
NZ (1) NZ237819A (ja)
PL (1) PL166736B1 (ja)
PT (1) PT97375B (ja)
SA (1) SA91110352B1 (ja)
WO (1) WO1991016306A1 (ja)
ZA (1) ZA912782B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process
ES2137932T3 (es) * 1990-09-28 2000-01-01 Smithkline Beecham Corp Procedimiento para la preparacion de analogos de camptotecina solubles en agua, asi como los compuestos 10-hidroxi-11-alcoxi-6-camptotecina.
GB9300309D0 (en) * 1993-01-08 1993-03-03 Smithkline Beecham Plc Process
US6218421B1 (en) * 1999-07-01 2001-04-17 Smithkline Beecham P.L.C. Method of promoting smoking cessation
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
WO2005074387A2 (en) * 2003-12-30 2005-08-18 Sun Pharmaceutical Industries Limited Novel crystal forms of 4-[2-di-n-propylamino)ethyl]-2 (3h)- indolone hydrochloride
US7378439B2 (en) * 2004-01-20 2008-05-27 Usv, Ltd. Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
WO2005105741A1 (en) * 2004-02-11 2005-11-10 Sun Pharmaceutical Industries Limited Substantially pure 4-[2-(di-n-propylamino)ethyl]-2(3h)-indolone hydrochloride
WO2005080333A1 (en) * 2004-02-19 2005-09-01 Torrent Pharmaceuticals Ltd Process for purification of ropinirole
US20070254941A1 (en) * 2006-04-21 2007-11-01 Glenmark Pharmaceuticals Limited Subtantially pure ropinirole hydrochloride, polymorphic form of ropinirole and process for their preparation
CN103130704B (zh) * 2013-03-11 2019-03-22 上海奥博生物医药技术有限公司 一种制备4-(2-羟乙基)-1,3-二氢-2h-吲哚-2-酮的新方法
CN103145604A (zh) * 2013-03-19 2013-06-12 上海奥博生物医药技术有限公司 一种制备罗匹尼罗关键中间体的方法
CN105418482A (zh) * 2015-11-23 2016-03-23 东南大学 一种改进的盐酸罗匹尼罗的制备方法
CN108440376B (zh) * 2018-05-08 2020-06-05 中国科学院成都生物研究所 一种盐酸罗匹尼罗的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1154976A (en) * 1967-02-21 1969-06-11 Pfizer Ltd N-Phenyl Indoline Derivatives
JPS53101333A (en) * 1977-02-14 1978-09-04 Sagami Chem Res Center 3-acyloxymethyl-3,4:5,6-diepoxycyclohexane-1,2-diol and
IT1171624B (it) * 1980-11-12 1987-06-10 Thomae Gmbh Dr K Indolinoni dotati di proprieta' farmaceutiche e procedimento per la loro produzione
US4588790A (en) * 1982-03-24 1986-05-13 Union Carbide Corporation Method for fluidized bed polymerization
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
US4593033A (en) * 1985-04-24 1986-06-03 Merck & Co., Inc. Substituted indeno[2,1-c] pyridines useful as calcium channel blockers
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
GB8714371D0 (en) * 1987-06-19 1987-07-22 Smith Kline French Lab Process
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process

Also Published As

Publication number Publication date
SA91110352B1 (ar) 2001-11-12
PT97375B (pt) 1998-08-31
IL111028A (en) 1995-11-27
FI924674A0 (fi) 1992-10-15
HUT64742A (en) 1994-02-28
IL111030A (en) 1995-11-27
AU7656291A (en) 1991-11-11
NO924028D0 (no) 1992-10-16
GB9008605D0 (en) 1990-06-13
AP9100251A0 (en) 1991-04-30
IL111028A0 (en) 1994-11-28
JPH10251205A (ja) 1998-09-22
GR3022261T3 (en) 1997-04-30
IE911262A1 (en) 1991-10-23
ZA912782B (en) 1992-11-25
NO178396C (no) 1996-03-20
JP2788548B2 (ja) 1998-08-20
EP0526529B1 (en) 1996-10-16
EP0526529A1 (en) 1993-02-10
IL97867A0 (en) 1992-06-21
AU3566993A (en) 1993-06-03
AU640006B2 (en) 1993-08-12
PT97375A (pt) 1992-01-31
IL111029A0 (en) 1994-11-28
ATE144251T1 (de) 1996-11-15
CA2080221A1 (en) 1991-10-18
DE69122753D1 (de) 1996-11-21
IL111029A (en) 1995-11-27
CN1027892C (zh) 1995-03-15
NO1999012I1 (no) 1999-06-18
CN1056686A (zh) 1991-12-04
NO178396B (no) 1995-12-11
IL97867A (en) 1995-11-27
MY109628A (en) 1997-03-31
HU214822B (hu) 1998-06-29
KR0180215B1 (ko) 1999-03-20
HK3097A (en) 1997-01-10
FI101148B (fi) 1998-04-30
JPH05506029A (ja) 1993-09-02
CA2080221C (en) 2000-11-14
IL111030A0 (en) 1994-11-28
NO924028L (no) 1992-10-16
MA22133A1 (fr) 1991-12-31
US5336781A (en) 1994-08-09
PL166736B1 (pl) 1995-06-30
FI924674A (fi) 1992-10-15
NZ237819A (en) 1993-05-26
ES2094812T3 (es) 1997-02-01
CY1981A (en) 1997-09-05
AP184A (en) 1992-06-30
DE69122753T2 (de) 1997-05-07
HU9203261D0 (en) 1992-12-28
WO1991016306A1 (en) 1991-10-31
JP3044013B2 (ja) 2000-05-22
AU646771B2 (en) 1994-03-03

Similar Documents

Publication Publication Date Title
DK0526529T3 (da) "Forbedret fremgangsmåde til fremstilling af substituerede indolonderivater"
DK0522269T3 (da) Fremgangsmåde til fremstilling af enzymsammensætninger
DK250689D0 (da) Fremgangsmaade til fremstilling af napthalenderivater
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
EE03027B1 (et) Meetod 8-klorokinolooni derivaatide valmistamiseks
NO914056D0 (no) Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat
NO912303L (no) Fremgangsmaate for fremstilling av en amorf form av gemfibrozil
FI953361A (fi) Menetelmä substituoitujen indolonijohdannaisten valmistamiseksi
DK314988A (da) Fremgangsmaade til fremstilling af 6-deoxyguaninderivater
DK56694A (da) Fremgangsmåde til fremstilling af cephemderivater
NO914985L (no) Fremgangsmaate for fremstilling av 15-nitro-tabersonin-derivater
DK0427287T3 (da) Fremgangsmåde til fremstilling af indoler
NO912980D0 (no) Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenderivater
DK143889A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK88091A (da) Fremstilling af pentansyrederivater
DK293589A (da) Fremgangsmaade til fremstiling af lactolderivater
NO914452D0 (no) Fremgangsmaate for fremstilling av isokinolinderivater
DK0377437T3 (da) Fremgangsmåde til fremstilling af 2,4-diamino-6-piperidinylpyrimidin-3-N-oxid
DK184789A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK0433218T3 (da) Fremgangsmåde til fremstilling af aminotriazinderivater
NO174196C (no) Fremgangsmåte for fremstilling av omega-decenol
DK631888A (da) Fremgangsmaade til fremstilling af 1,5-benzothiazepinderivater
SE9001671D0 (sv) Preparation process of thieno-triazolo-diazepine derivatives
DK0965591T3 (da) Fremgangsmåde til fremstilling af (S)-3-methyl-1-(2-piperidino-phenyl)-1-butylamin
DK170790D0 (da) Fremgangsmaade til fremstilling af alkansyrederivater